Speakers

Professor Adil Mardinoglu works as a Professor of Systems Biology at King’s College London in UK and Science for Life Laboratory (SciLifeLab) at KTH-Royal Institute of Technology in Sweden. At the helm of a 30-strong research team, Professor Mardinoglu spearheads the development of novel treatment strategies for metabolic and neurodegenerative diseases, as well as certain cancers, blending multiomics, systems biology, AI and experimental biology with drug development. 

A key contributor to the Swedish Human Protein Atlas program, Professor Mardinoglu has played a crucial role in constructing a comprehensive human tissue, subcellular, and pathology atlas. He has also been instrumental in developing the phenome atlas within the International Human Phenome Atlas Initiative. His scholarly output includes more than 250 research and review articles published in journals such as Science, Nature, Nature Biotechnology, Cell Metabolism, Nature Metabolism, Nature Communications, PNAS, Cell Reports, Molecular Systems Biology, and EbioMedicine. Furthermore, as a co-founder of SZA Longevity, ScandiBio Therapeutics, ScandiEdge Therapeutics, and Trustlife Therapeutics, he has made substantial entrepreneurial contributions to the biotech sector.